Jörg Striessnig, Ph.D.
Affiliations: | University of Innsbruck, Innsbruck, Tirol, Austria |
Area:
Calcium ChannelsGoogle:
"Jörg Striessnig"Mean distance: 15.51 (cluster 32) | S | N | B | C | P |
Parents
Sign in to add mentor| William A. Catterall | post-doc | University of Washington | |
| Hartmut Glossmann | research scientist | University of Innsbruck |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Alexander SPH, Mathie AA, Peters JA, et al. (2023) The Concise Guide to PHARMACOLOGY 2023/24: Ion channels. British Journal of Pharmacology. S145-S222 |
| Ortner NJ, Sah A, Paradiso E, et al. (2023) The human channel gating-modifying A749G CACNA1D (Cav1.3) variant induces a neurodevelopmental syndrome-like phenotype in mice. Jci Insight. 8 |
| Filippini L, Ortner NJ, Kaserer T, et al. (2023) Ca 1.3-selective inhibitors of voltage-gated L-type Ca channels: Fact or (still) fiction? British Journal of Pharmacology |
| Török F, Tezcan K, Filippini L, et al. (2022) Germline de novo variant F747S extends the phenotypic spectrum of CACNA1D Ca2+ channelopathies. Human Molecular Genetics |
| Siller A, Hofer NT, Tomagra G, et al. (2022) rβ2-subunit alternative splicing stabilizes Cav2.3 Ca channel activity during continuous midbrain dopamine neuron-like activity. Elife. 11 |
| Shin J, Kovacheva L, Thomas D, et al. (2022) Ca1.3 calcium channels are full-range linear amplifiers of firing frequencies in lateral DA SN neurons. Science Advances. 8: eabm4560 |
| Alexander SP, Mathie A, Peters JA, et al. (2021) THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Ion channels. British Journal of Pharmacology. 178: S157-S245 |
| Striessnig J. (2021) Voltage-Gated Ca-Channel α1-Subunit Missense Mutations: Gain or Loss of Function - Implications for Potential Therapies. Frontiers in Synaptic Neuroscience. 13: 634760 |
| Hofer NT, Pinggera A, Nikonishyna YV, et al. (2021) Stabilization of negative activation voltages of Cav1.3 L-Type Ca-channels by alternative splicing. Channels (Austin, Tex.). 15: 38-52 |
| Ortner NJ, Kaserer T, Copeland JN, et al. (2020) De novo CACAN1D Ca channelopathies: clinical phenotypes and molecular mechanism. Pflugers Archiv : European Journal of Physiology |